Botulinum toxin injections and hypertonic upper limbs. Which functional results?;Membres supérieurs fonctionnels hypertoniques et toxine botulique. Quels résultats fonctionnels?

Annales de Readaptation et de Medecine Physique

Volumn 48, Issue 4, 2005, Pages 172-179

  Ferrapie, A L ^a   Vieillart, A ^b   Saint Cast, Y ^c   Menei, P ^a   Richard, I ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b Saint Sauveur Clinic   (France)

^c Centre de la Main   (France)

Author keywords

Botulinum toxin; Evaluation; Hand functional measure; Hypertonia; Prehension; Spasticity

Indexed keywords

BOTULINUM TOXIN A; SPASMOLYTIC AGENT;

ADOLESCENT; ADULT; ARM DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FINGER; HAND FUNCTION; HUMAN; MALE; MOTOR NEURON DISEASE; MUSCLE HYPERTONIA; NERVE STIMULATION; PAIN ASSESSMENT; PATIENT SATISFACTION; SPASTICITY; VISUAL ANALOG SCALE; VOLUNTARY MOVEMENT; WRIST;

EID: 17444380080     PISSN: 01686054     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annrmp.2004.10.007     Document Type: Article

References (44)

1. B.T. Agana, and S.A. Yablon Clinical effectiveness of botulinum toxin in distal upper extremity spasticity among patients with traumatic brain injury Arch Phys Med Rehabil 75 1994 1063 (abstract)
2. I. Autti-Ramö, A. Larsen, J. Peltonen, A. Taimo, and L. Von Wendt Botulinum toxin injection as an adjunct when planning hand surgery in children with spastic hemiplegia Neuropediatrics 31 2000 4 8
3. ®) with placebo in upper limb spasticity after stroke Stroke 31 2000 2402 2406
4. A.M.O. Bakheit, S. Pittock, A.P. Moore, M. Wurker, S. Otto, and F. Erbguth A randomized, double-blind, placebo-controlled study of the efficacy and safety of toxin type A in upper limb spasticity in patients with stroke Eur J Neurol 8 2001 559 565
5. F. B́thoux, and P. Calmels Guide des outils de mesure et d'́valuation en ḿdecine physique et de ŕadaptation 2003 Ed Frison-Roche
6. B.B. Bhakta, J.A. Cozens, J.M. Bamford, and M.A. Chamberlain Use of botulinum toxin in stroke patients with severe upper limb spasticity J. Neurol. Neurosurg. Psychiatry 61 1996 30 35
7. B.B. Bhakta, J.A. Cozens, M.A. Chamberlain, and J.M. Bamford Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial J Neurol Neurosurg Psychiatry 69 2000 217 221
8. R.W. Bohannon, and M.B. Smith Interrater reliability of a modified ashworth scale of muscle spasticity Phys Ther 1987 206 207
9. A. Brashear, M.F. Gordon, E. Elovic, V.D. Kassicieh, C. Marciniak, and M. Do Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke N Engl J Med 347 2002 395 400
10. E. Chaleat-Valayer, P. Calmels, and V. Gautheron Injections de toxine botulique A et spasticit́ du membre suṕrieur:: l'exṕrience st́phanoise D. Ṕrennou B. Bussel J. Ṕlissier La spasticit́ 2001 Masson Paris, France 137 148
11. T.K. Das, and D.M. Park Effect of treatment with botulinum toxin on spasticity Postgrad Med J 65 1989 208 210
12. T. Dubert, P. Voche, C. Dumontier, and A. Dinh The DASH questionnaire. French translation of a trans-cultural adaptation Chir Main 20 4 2001 294 302
13. E. Duprey, P. Dehail, E. Cuny, P. Arń, B. Fernandez, and P.A. Joseph Toxine botulique et traumatisme crânien Ann Readapt Med Phys 46 2003 303 306
14. C. Gable, E. Joubert, and J. X́nard Le bilan 400 points Revue de ŕadaptation fonctionnelle, professionnelle et sociale 19 1989 55 58
15. C. Gable, N. Chau, J. Xenard, and J.M. Andŕ Accords inter-juges d'une mesure fonctionnelle analytique du membre suṕrieur. Inter-rater agreements of an analytic functional measure of the upper limb Rev Epid́m et Sant́ Publ 41 1993 72 83
16. C. Gable, J. X́nard, and J.M. Andŕ Bilan 400 points Journal d'Ergoth́rapie 18 1996 47 58
17. C. Gable, J. Xenard, E. Makiela, and N. Chau Évaluation fonctionnelle de la main. Bilan 400 points et tests chiffŕs Ann Readapt Med Phys 40 1997 95 101
18. P. Girlanda, A. Quartarone, S. Sinicropi, C. Nicolosi, M.L. Roberto, and G. Picciolo Botulinum toxin upper limb spasticity: study of reciprocal inhibition between forearm muscles Neuroreport 8 1997 3039 3044
19. J.M. Gracies Physiological effects of botulinum toxin in spasticity Mov Disord 19 Suppl 8 2004 S120 S128
20. A.M. Grazko, B.K. Polo, and B. Jabbari Botulinum toxin A for spasticity, muscle spasms, and rigidity Neurology 45 1995 712 717
21. S. Hesse, C. Werner, A. Bardeleben, and B. Brandl-Hesse Management of upper and lower limb spasticity in neurorehabilitation D. Ṕrennou B. Bussel J. Ṕlissier La spasticit́ 2001 Masson Paris, France 119 127
22. E.A. Hurvitz, G.E. Conti, and S.H. Brown Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection Arch Phys Med Rehabil 84 2003 444 454
23. C. Leblond, F. Pellas, J.L. Chapet, and M. Enjalbert Mouvements anormaux chez le ćŕbroĺś vasculaire M. Enjalbert J. Touchon J. Ṕlissier Les mouvements anormaux 2004 Masson Paris, France 121 128
24. C. Luquet, N. Chau, M. Nadif, F. Guillemin, C. Gavillot, and D. Petry Unidimensionnalit́ d'une mesure fonctionnelle pour des malades ayant une ĺsion du membre suṕrieur Rev Epid́miol et Sant́ Publ 44 1996 248 261
25. B. Memin, P. Pollak, M. Hommel, and J. Perret Traitement de la spasticit́ par la toxine botulique Rev Neurol 148 1992 212 214
26. P. Minaire La mesure d'ind́pendance fonctionnelle:: historique, pŕsentation, perspectives J Readapt Med 11 1991 168 174
27. G. Monnier, B. Parratte, L. Tatu, A. Cosson, F. Michel, and G. Metton Apport de l'EMG dans l'utilisation de la toxine botulique Ann Readapt Med Phys 46 2003 380 385
28. C.F. O'Brien Injection techniques for botulinum toxin using electromyography and electrical stimulation Muscle Nerve Suppl. 20 1997 S176 S180
29. D.T. Palmer, L.J. Horn, and R.L. Harmon Botulinum toxin treatment of lumbrical spasticity: a brief report Am J Phys Med Rehabil 77 1998 348 350
30. G. Pavesi, R. Brianti, D. Medici, P. Mammi, A. Mazzucchi, and D. Mancia Botulinum toxin type A in the treatment of upper limb spasticity among patients with traumatic brain injury J Neurol Neurosurg Psychiatry 64 1998 419 420
31. S.H. Pierson, D.I. Katz, and D. Tarsy Botulinum toxin A in the treatment of spasticity: functional implications and patient selection Arch Phys Med Rehabil 77 1996 717 721
32. L. Pullman, P. Greene, S. Fahn, and F.S. Pedersen Approach to the treatment of limb disorders with botulinum toxin A: Experience with 187 patients Arch Neurol 53 1996 617 624
33. F. Reiter, M. Danni, M.G. Ceravolo, and L. Provinciali Disability changes after treatment of upper limb spasticity with botulinum toxin J Neuro Rehab 10 1996 47 52
34. Rémy-Néris O, Denys P, Azouvi P, Jouffroy A, Faivre S, Laurans A, et al. Spasticité. Encycl Méd Chir (Elsevier Paris), Kinésithérapie-Médecine Physique-Réadaptation, 26-011-A-10, 1997, 8p.
35. D. Richardson, S. Edwards, G.L. Sheean, R.J. Greenwood, and A.J. Thompson The effect of botulinum toxin on hand function after incomplete spinal cord injury at the level of C5/6: a case report Clin Rehabil 11 1997 288 292
36. M. Rousseaux, O. Kozlowski, and J. Froger Efficacy of botulinum toxin A in upper limb function of hemiplegic patients J Neurol 249 2002 76 84
37. M. Rousseaux, M.J. Launay, and O. Kozlowski H́mipĺgie vasculaire:: int́r̂t de l'injection de toxine botulique au membre suṕrieur Ann Readapt Med Phys 46 2003 286 295
38. C. Sampaio, J.J. Ferreira, A.A. Pinto, M. Crespo, J.M. Ferro, and A. Castro-Caldas Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients Clin Rehab 11 1997 3 7
39. D.M. Simpson, D.N. Alexender, C.F. O'brien, and M. Tagliati Botulinum toxin type A in the treatment of upper extremity spasticity: a randomised, double blind, placebo-controlled trial Neurology 46 1996 1306 1310
40. S.J. Smith, E. Ellis, S. White, and A.P. Moore A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury Clin Rehab 14 2000 5 13
41. A. Viriyavejakul, R. Vachalathiti, and N. Poungvarin Botulinum treatment for post-stroke spasticity: low dose regime J Med Assoc Thai 81 1998 413 422
42. Y. Watanabe, A.M.O. Bakheit, and D.L. Mc Lellan A study of the effectiveness of botulinum toxin type A (Dysport®) in the management of muscle spasticity Disabil Rehabil 20 1998 62 65
43. H. Woldag, and H. Hummelsheim Is the reduction of spasticity by botulinum toxin a beneficial for the recovery of motor function of arm and hand in stroke patients? Eur Neurol 50 2003 165 171
44. A.S. Yablon, T.B. Agana, B.C. Ivanhoe, and C. Boake Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: an open-labeled trial Neurology 47 1996 939 944